VIDEO: MGMA explains why the COVID-19 public health emergency extension is critical

The public health emergency was recently extended by the Department of Health and Human Services (HHS) on Oct. 13. The extension ensures healthcare organizations are still afforded the flexibilities granted during the early days of the pandemic and avoids the "telehealth cliff," according to Ernst. 

A PHE lasts for 90 days, but can be renewed and extended by the HHS secretary. The COVID-19 PHE has leveraged emergency waivers, regulations, enforcement discretion and sub-regulatory guidance to offer more flexibilities to providers and improve access to care.

HHS has previously stated it will provide 60 days' notice before ending the PHE to give providers time to adjust. However, extending the PHE while the pandemic is still ongoing is critical, according to Ernst. 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.